LRRC6 Protein (DYKDDDDK Tag)
-
- Target See all LRRC6 Proteins
- LRRC6 (Leucine Rich Repeat Containing 6 (LRRC6))
- Protein Type
- Recombinant
-
Origin
- Human
-
Source
- Insect cells (Sf9)
- Purification tag / Conjugate
- This LRRC6 protein is labelled with DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Characteristics
-
- Recombinant human LRRC6 (full length, C-term DDK tag) protein expressed in Sf9 cells.
- Produced with end-sequenced ORF clone
- Purity
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product LRRC6 Protein
-
-
- Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Comment
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 50 mM Tris-HCl, pH 8.0, 100 mM glycine, 10 % glycerol. Store at -80C. Avoid repeated freeze-thaw cycles. Stable for at least 3 months from receipt of products under proper storage and handling conditions.
- Storage
- -80 °C
- Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- LRRC6 (Leucine Rich Repeat Containing 6 (LRRC6))
- Alternative Name
- Lrrc6 (LRRC6 Products)
- Synonyms
- LRTP Protein, Lrtp Protein, Tslrp Protein, CILD19 Protein, TSLRP Protein, lrrc6l Protein, leucine rich repeat containing 6 (testis) Protein, leucine rich repeat containing 6 Protein, Lrrc6 Protein, LRRC6 Protein, lrrc6 Protein
- Background
- The protein encoded by this gene contains several leucine-rich repeat domains and appears to be involved in the motility of cilia. Defects in this gene are a cause of primary ciliary dyskinesia-19 (CILD19). Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 4, 11 and 22.
- Molecular Weight
- 54.3 kDa
- NCBI Accession
- NP_036604
- Pathways
- M Phase
-